Crohn's Disease-Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism. Briggs, K; Tomar, V; Ollberding, N; Haberman, Y; Bourgonje, AR; Hu, S; Chaaban, L; Sunuwar, L; Weersma, RK; Denson, LA; Melia, JM P. Inflammatory Bowel Diseases. 2024; 30:1379-1388.

All (remains) in the family? Using healthy relatives to define Crohn's gut microbiome alterations. Amir, A; Haberman, Y. Cell Reports Medicine. 2024; 5:101651.

Machine-learning-based integrative -'omics analyses reveal immunologic and metabolic dysregulation in environmental enteric dysfunction. Zulqarnain, F; Zhao, X; Setchell, KD R; Sharma, Y; Fernandes, P; Srivastava, S; Shrivastava, A; Ehsan, L; Jain, V; Raghavan, S; Brown, DE; Moore, SR; Ali, SA; Syed, S. iScience. 2024; 27:110013.

Mo1794 CROHN'S DISEASE-ASSOCIATED PATHOGENIC MUTATION IN MANGANESE TRANSPORTER ZIP8 SHIFTS THE ILEAL AND RECTAL MUCOSAL MICROBIOTA IMPLICATING ABERRANT BILE ACID METABOLISM. Briggs, K; Tomar, V; Ollberding, N; Haberman, Y; Bourgonje, AR; Hu, S; Chaaban, L; Sunuwar, L; Weersma, RK; Denson, LA; Melia, JP. Gastroenterology. 2024; 166:s-1114.

Su1898 LACK OF GUT MICROBIOME RECOVERY WITH SPINAL CORD INJURY REHABILITATION. Arie, AG; Toren, I; Hadar, R; Braun, T; Efroni, G; Zeilig, G; Haberman, Y; Amir, A. Gastroenterology. 2024; 166:s-865.

Su1888 THE GUT MICROBIOME AS A REPORTER OF HEALTH, AND ITS ASSOCIATIONS WITH DIFFERENT EXPOSURES. Braun, T; Hadar, R; Efroni, G; Haaronian, O; Leshem, R; Abbas, H; Amir, A; Haberman, Y. Gastroenterology. 2024; 166:s-860.

Tu1754 MODELS FOR PREDICTING CROHN DISEASE (CD) EXACERBATION USING SERUM AND FECAL METABOLOMICS. Levhar, N; Hadar, R; Braun, T; Efroni, G; Naamneh, R; Agranovich, B; Asher, AT; Selinger, L; Picard, O; Lahat, A; Eliakim, R; Kopylov, U; Ben-Horin, S; Amir, A; Haberman, Y. Gastroenterology. 2024; 166:s-1407.

DOP29 Capsule endoscopy-guided proactive treatment versus standard treatment of patients with quiescent Crohn’s Disease: The CURE-CD randomized controlled trial. Ben-Horin, S; Lahat, A; Ungar, B; Ukashi, O; Yablecovitch, D; Amitai, MM; Haberman, Y; Selinger, L; Talan-Asher, A; Kriger-Sharabi, O; Yanai, H; Dotan, I; Kopylov, U; Eliakim, R. Journal of Crohn's and Colitis. 2024; 18:i125-i126.

DOP09 Models for predicting Crohn Disease (CD) exacerbation using serum and fecal metabolomics. Levhar, N; Hadar, R; Braun, T; Efroni, G; Naamneh, R; Agranovich, B; Talan Asher, A; Selinger, L; Picard, O; Lahat, A; Eliakim, A; Kopylov, U; Ben-Horin, S; Amir, A; Haberman, Y. Journal of Crohn's and Colitis. 2024; 18:i88-i89.

P297 Differences in disease characteristics and treatment exposures between pediatric- and adult-onset Ulcerative Colitis. Granot, M; Kopylov, U; Nachum, N; Krauthammer, A; Abitbol, CM; Ben Horin, S; Weiss, B; Haberman, Y. Journal of Crohn's and Colitis. 2024; 18:i670-i671.